Skip to content

Comparison of Oral Versus Vaginal Misoprostol for Labour Induction at Term

Comparison of Oral Versus Vaginal Misoprostol for Labour Induction at Term

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05957666
Enrollment
176
Registered
2023-07-24
Start date
2023-06-16
Completion date
2023-12-16
Last updated
2023-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Labour With Misoprostol

Keywords

induction of labour, misoprostol

Brief summary

A randomised control trial to compare oral and vaginal misoprostol for induction of labour in term patients.The objective is to determine whether use of standardised vaginal misoprostol regimen will result in decreased cesaerean section rate among women with bishop score of lessthan or equal to 6 who require induction of labpour at term compared to oral misoprostol regimen.

Detailed description

The objective of study is to determine whether the use of standardised vaginal misoprostol regimen will result in decreased cesaerean section rate among women with bishop score of less than or equal to 6 who require induction of labour at term compared to oral misoprostol regimen.It is a randomised control trial conducted in department of obs and gynae unit 1 from june 2023. Total 176 patients are included in this study and they will be randomised by envelope method to recieve either oral or vaginal misoprostol in a dose of 50microgram.In both groupds dose will be repeated after 6 hours if required.Maximum 2 doses will be given.patients will be monitored for uterine contractions and fetal hearts.Vaginal examination will be done at 4hours and 8 hours following misoprostol dose or earlier if patient complains of leaking and labour pains.Membranes will be ruptured once cervical dilatation is greater than 3cm.in absence of adequate uterine contractions oxytocin infusion will be started.Fetal hearts will be monitored every 30 minutes from time of induction.Progress of labour will be assessed through partogram.

Interventions

oral misoprostol 50 microgram repeated after 6 hours if required

DRUGvaginal misoprostol

vaginal misoprostol 50 microgram repeated after 6 hours if required

Sponsors

Services Institute of Medical Sciences, Pakistan
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

patients will either recieve oral or vaginal misoprostol by envelope method ina dose of 50microgram.Total of 176 envelopes are placed in a concealed box.Neither the doctor nor the patient knows.

Intervention model description

Total 176 patient included in this study.Patients will be randomised by envelop method to recieve either oral or vaginal misoprostol in a dose of 50microgram.

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Cephalic presentation Prelabour rupture of membranes Singleton pregnancies reaching 41 weeks G1 to G4 Bishop score of less than or equal to 6 Medical disorders(GDM,PIH) -

Exclusion criteria

Previous uterine scar Antepartum hemorrhage Cephalopelvic disproportion Multiple gestation Multiparity Oligohydramnios/polyhydramnios IUGR Severe systemic illness like pre eclampsia,eclampsia,cardiac,hepatic,renal disease PPROM \-

Design outcomes

Primary

MeasureTime frameDescription
vaginal birthvaginal birth within 24 hours of admissionvaginal birth within 24 hours of admission with 2 doses of misoprostol given 6 hours apart

Secondary

MeasureTime frameDescription
cesaerean sectionwithin 24 hourscesaerean section if patient doesnt go in labour despite 2 doses or fetal distress occurs
induction to delivery intervalwithin 24 hoursmeasured from 1st dose till delivery of patient
fetal distresswithin 24 hoursfetal distress measured by non reactive CTG or meconium stained amniotic fluid
uterine hyperstimulationmore than 10 cotractions in every 10 minutesmore than 5 contractions in every 10 minutes

Countries

Pakistan

Contacts

Primary ContactTayyiba Wasim, FCPS
tayyibawasim@yahoo.com03008400197
Backup ContactKalsoom Waheed, FCPS
zainabmohsin09@gmail.com03214262687

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026